US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 1.090
  • +0.030+2.83%
Close Dec 2 16:00 ET
  • 1.300
  • +0.210+19.27%
Post 19:59 ET
85.30MMarket Cap6.81P/E (TTM)

About CytomX Company

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Company Profile

SymbolCTMX
Company NameCytomX
Listing DateOct 8, 2015
Issue Price12.00
Founded2010
CEODr. Sean A. McCarthy, D.Phil.
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address151 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1913
Phone1-605-515-3185
Websitehttp://www.cytomx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sean A. McCarthy, D.Phil.
  • Chief Executive Officer and Chairman of the Board
  • 2.61M
  • Christopher W. Ogden
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Marcia Belvin
  • Senior Vice President and Chief Scientific Officer
  • 1.21M
  • Jeffrey B. Landau
  • Senior Vice President, Chief Business Officer, and Head of Strategy
  • 1.05M
  • Dr. Alan Ashworth
  • Independent Director
  • 69.12K
  • Dr. Mani Mohindru, PhD
  • Independent Director
  • 78.62K
  • Matthew P. Young
  • Lead Independent Director
  • 105.12K
  • Dr. Elaine V. Jones, PhD
  • Independent Director
  • 75.12K
  • Halley E. Gilbert
  • Independent Director
  • 80.62K
  • James R. Meyers
  • Independent Director
  • 77.12K
  • Dr. Zhen Su
  • DIrector
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data